Association between VDR polymorphisms and breast cancer: An updated and comparative meta-analysis of crude and adjusted odd ratios

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 847-853

  Huang, Qian Qian ^a   Liao, Yu Yi ^a   Ye, Xiao Hua ^a   Fu, Jin Jian ^a,b   Chen, Si Dong ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b Liuzhou Municipal Maternity and Child Healthcare Hospital   (China)

Author keywords

Breast cancer; Meta analysis; Polymorphism; Risk; Vitamin D receptor

Indexed keywords

CALCITRIOL RECEPTOR; TUMOR MARKER;

ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; PATHOLOGY; PROGNOSIS; RISK;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, CALCITRIOL; TUMOR MARKERS, BIOLOGICAL;

EID: 84894677493     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.847     Document Type: Article

References (44)

1. Abbas S, Nieters A, Linseisen J, et al (2008). Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res, 10, R31.
2. Anderson LN, Cotterchio M, Cole DE, Knight JA (2011). Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev, 20, 1708-17.
3. Bretherton-Watt D, Given-Wilson R, Mansi JL, et al (2001). Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer, 85, 171-5.
4. Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N (2003). Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med, 35, 550-5.
5. Chakraborty A, Mishra AK, Soni A, et al (2009). Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev, 32, 386-94.
6. Chen WY, Bertone-Johnson ER, Hunter DJ, et al (2005). Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 2335-9.
7. Cui J, Shen K, Shen Z, et al (2001). [Relationship of vitamin D receptor polymorphism with breast cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 18, 286-8.
8. Curran JE, Vaughan T, Lea RA, et al (1999). Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer, 83, 723-6.
9. Dalessandri KM, Miike R, Wiencke JK, et al (2012). Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study. J Am Coll Surg, 215, 652-7.
10. Dunning AM, McBride S, Gregory J, et al (1999). No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis, 20, 2131-5.
11. Duval S, Tweedie R (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455-63.
12. Engel LS, Orlow I, Sima CS, et al (2012). Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev, 21, 1856-67.
13. Fuhrman BJ, Freedman DM, Bhatti P, et al (2013). Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res, 33, 543-51.
14. Gapska P, Scott RJ, Serrano-Fernandez P, et al (2009). Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat, 115, 629-33.
15. Guy M, Lowe LC, Bretherton-Watt D, et al (2004). Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res, 10, 5472-81.
16. Hefler LA, Tempfer CB, Grimm C, et al (2004). Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer, 101, 264-9.
17. Hou MF, Tien YC, Lin GT, et al (2002). Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat, 74, 1-7.
18. Huang J, Huang J, Ma Y, et al (2013). The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis. Mol Biol Rep, 40, 4219-25.
19. Huang J, Yang J, Wang H, et al (2013). The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis. Tumour Biol, 34, 1833-8.
20. Ingles SA, Garcia DG, Wang W, et al (2000). Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control, 11, 25-30.
21. John EM, Schwartz GG, Koo J, et al (2007). Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol, 166, 1409-19.
22. Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6.
23. Lopes N, Sousa B, Martins D, et al (2010). Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer, 10, 483.
24. Lowe LC, Guy M, Mansi JL, et al (2005). Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer, 41, 1164-9.
25. Lundin AC, Soderkvist P, Eriksson B, et al (1999). Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res, 59, 2332-4.
26. McCullough ML, Bostick RM, Mayo TL (2009). Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr, 29, 111-32.
27. McCullough ML, Stevens VL, Diver WR, et al (2007). Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res, 9, R9.
28. McKay JD, McCullough ML, Ziegler RG, et al (2009). Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev, 18, 297-305.
29. Mishra DK, Wu Y, Sarkissyan M, et al (2013). Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One, 8, e57967.
30. Newcomb PA, Kim H, Trentham-Dietz A, et al (2002). Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1503-4.
31. Rollison DE, Cole AL, Tung KH, et al (2012). Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat, 132, 683-91.
32. Shab-Bidar S, Neyestani TR, Djazayery A (2011). Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord, 11, 12.
33. Shahbazi S, Alavi S, Majidzadeh-A K, et al (2013). BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol, 30, 393.
34. Sillanpaa P, Hirvonen A, Kataja V, et al (2004). Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics, 14, 239-45.
35. Sinotte M, Rousseau F, Ayotte P, et al (2008). Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer, 15, 975-83.
36. Tang C, Chen N, Wu M, et al (2009). Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat, 117, 391-9.
37. Trabert B, Malone KE, Daling JR, et al (2007). Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res, 9, R84.
38. VandeVord PJ, Wooley PH, Darga LL, et al (2006). Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat, 100, 103-7.
39. Wang H, Wang W, Yang D, Wang S (2013). TaqI polymorphism of VDR gene contributes to breast cancer risk. Tumour Biol, doi:10.1007/s13277-013-1011-9.
40. Wang J, He Q, Shao YG, et al (2013). Associations between vitamin D receptor polymorphisms and breast cancer risk. Tumour Biol, doi:10.1007/s13277-013-0967-9.
41. Wedren S, Magnusson C, Humphreys K, et al (2007). Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 16, 1775-83.
42. Wells GA, Shea B, O'Connell D, et al (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 28 August 2013]. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
43. Yao S, Zirpoli G, Bovbjerg DH, et al (2012). Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res, 14, R58.
44. Zhou ZC, Wang J, Cai ZH, et al (2013). Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility. Tumour Biol, doi:10.1007/s13277-013-0919-4.